Experienced in Familial Adenomatous Polyposis

Qian J. Jiang

Jiefang Avenue. 1095, 
Wuhan, CN 
Experienced in Familial Adenomatous Polyposis
Jiefang Avenue. 1095, 
Wuhan, CN 
OverviewLocationsClinical Research

Overview

Qian Jiang practices in Wuhan, China. Mr. Jiang is rated as an Experienced expert by MediFind in the treatment of Familial Adenomatous Polyposis. His top areas of expertise are Chronic Myelogenous Leukemia (CML), Leukemia, Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Thrombectomy.

His clinical research consists of co-authoring 722 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Familial Adenomatous Polyposis.

Gender
Male

Locations

Jiefang Avenue. 1095, Wuhan, 430030, China
Other Locations
158 Shangtang Road, Hangzhou, 310014, China
North Branch, Chongqing, 401147, China
36 Sanhao Street, Shenyang, 110004, China
457 Zhongshan Road, Dalian, 116023, China
438 North Jiefang Street, Zhenjiang, 212001, China
11 Xi Zhi Men South Street, Beijing, 100044, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase II Multi-center, Randomized, Open-label Study of Ponatinib in Chinese Patients With Chronic Myeloid Leukemia Who Have Failed Prior TKIs or With T315I Mutation, or Ph+ALL Who Have Failed Prior TKIs or With T315I Mutation
A Phase II Multi-center, Randomized, Open-label Study of Ponatinib in Chinese Patients With Chronic Myeloid Leukemia Who Have Failed Prior TKIs or With T315I Mutation, or Ph+ALL Who Have Failed Prior TKIs or With T315I Mutation
Enrollment Status: Active_not_recruiting
Publish Date: April 04, 2025
Intervention Type: Drug
Study Drug: Ponatinib
Study Phase: Phase 2
A Single-arm, Open-label, Dose Escalation and Dose Expansion Phase 1 Trial to Determine the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TGRX-678 in Patients With Refractory or Advanced CML
A Single-arm, Open-label, Dose Escalation and Dose Expansion Phase 1 Trial to Determine the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TGRX-678 in Patients With Refractory or Advanced CML
Enrollment Status: Active_not_recruiting
Publish Date: February 24, 2025
Intervention Type: Drug
Study Phase: Phase 1
View 1 Less Clinical Trial

722 Total Publications

Discussion on the technical standards for quality of life-modified eversion carotid endarterectomy
Discussion on the technical standards for quality of life-modified eversion carotid endarterectomy
Journal: Zhonghua yi xue za zhi
Published: January 21, 2026

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Jiang's expertise for a condition
ConditionClose
View All 11 Advanced Conditions
View All 119 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile